New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
09:14 EDTDRTXDurata Therapeutics price target raised to $22 from $19 at JMP Securities
JMP Securities increased its price target on Durata after the company priced its Dalvance drug at the higher end of the range expected by the firm. The firm reiterates an Outperform rating on Durata.
News For DRTX From The Last 14 Days
Check below for free stories on DRTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 18, 2014
08:06 EDTDRTXDurata Therapeutics announces U.S. launch of Dalvance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use